![Roy C. Cosan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Roy C. Cosan
Direktor/Vorstandsmitglied bei
RealBio Technology, Inc.
Profil
Mr. Roy C.
Cosan is a Managing Director at Fjord Ventures LLC.
He is on the Board of Directors at RealBio Technology, Inc.
Mr. Cosan's experience includes 32 years with Johnson and Johnson.
He was Vice President of New Product Development at Janssen Pharmaceutica where he launched Risperdal and Reminly.
He was also a Vice President with the Johnson & Johnson Development Corp., the venture capital arm of J&J where he invested in 19 companies and held 11 board of director seats.
At J&J, he also built a virtual R&D capability for the J&J Pharma organization.
Mr. Cosan received his undergraduate degree from Western Michigan University.
Aktive Positionen von Roy C. Cosan
| Unternehmen | Position | Beginn |
|---|---|---|
RealBio Technology, Inc.
 RealBio Technology, Inc. BiotechnologyHealth Technology Develops cell and tissue culture technologies | Direktor/Vorstandsmitglied | 18.05.2010 |
Fjord Ventures Inc
 Fjord Ventures Inc Investment ManagersFinance Fjord Ventures invests in companies located in the United States. The firm targets companies operating in the fields of life sciences sectors. It provides financing for early stage capital requirements. | Private Equity Investor | 01.02.2010 |
Ehemalige bekannte Positionen von Roy C. Cosan
| Unternehmen | Position | Ende |
|---|---|---|
Johnson & Johnson Innovation - JJDC, Inc.
 Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC invests in private and public companies located across the globe. The firm focuses on innovative medicine, health equity and medtech sectors. It provides financing for seed, early, and later stage capital requirements. | Private-Equity-Analyst | 31.12.2008 |
Galileo Pharmaceuticals, Inc.
 Galileo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics and pharmaceuticals | Direktor/Vorstandsmitglied | 16.12.2008 |
TorreyPines Therapeutics, Inc. /Old/
 TorreyPines Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs | Direktor/Vorstandsmitglied | 06.10.2006 |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Corporate Officer/Principal | 31.12.1999 |
Renova Therapeutics, Inc.
 Renova Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of gene and peptide therapies | Präsident | - |
Ausbildung von Roy C. Cosan
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
45
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Health Technology |
RealBio Technology, Inc.
RealBio Technology, Inc. BiotechnologyHealth Technology Develops cell and tissue culture technologies | Health Technology |
Metronom Health, Inc.
 Metronom Health, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops and markets continuous glucose monitoring systems for diabetes management | Electronic Technology |
Johnson & Johnson Innovation - JJDC, Inc.
Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC invests in private and public companies located across the globe. The firm focuses on innovative medicine, health equity and medtech sectors. It provides financing for seed, early, and later stage capital requirements. | Finance |
Galileo Pharmaceuticals, Inc.
Galileo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics and pharmaceuticals | Health Technology |
Western Michigan University
 Western Michigan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TorreyPines Therapeutics, Inc. /Old/
TorreyPines Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs | Health Technology |
Fjord Ventures Inc
Fjord Ventures Inc Investment ManagersFinance Fjord Ventures invests in companies located in the United States. The firm targets companies operating in the fields of life sciences sectors. It provides financing for early stage capital requirements. | Finance |
Renova Therapeutics, Inc.
Renova Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of gene and peptide therapies | Health Technology |
Prelude Corp.
 Prelude Corp. BiotechnologyHealth Technology Develops breast cancer tools to manage early stage breast cancer | Health Technology |
Orchest Health Corp.
 Orchest Health Corp. Electronic Equipment/InstrumentsElectronic Technology Provides glucose monitoring sensors for diabetes | Electronic Technology |
